5-((3-(4-Bromophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-pentyl-2-thioxothiazolidin-4-one

Catalog No. :
ACTAFN590
CAS No. :
307953-08-8
Molecular Formula :
C24H22BrN3OS2
Molecular Weight :
512.50

IUPAC Name:(Z)-5-((3-(4-bromophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-pentyl-2-thioxothiazolidin-4-one

5-((3-(4-Bromophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-pentyl-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((3-(4-Bromophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-pentyl-2-thioxothiazolidin-4-one
IUPAC Name(Z)-5-((3-(4-bromophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-pentyl-2-thioxothiazolidin-4-one
MDL No.MFCD02675332
Molecular FormulaC24H22BrN3OS2
Molecular Weight512.50
SMILESO=C1N(CCCCC)C(S/C1=C\C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(Br)C=C4)=S
InChI KeyPVKYMGWWMVQQFZ-QNGOZBTKSA-N
Synonym(5Z)-5-{[3-(4-bromophenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-3-pentyl-2-sulfanylidene-1,3-thiazolidin-4-one;4-Thiazolidinone, 5-[[3-(4-bromophenyl)-1-phenyl-1H-pyrazol-4-yl]methylene]-3-pentyl-2-thioxo-;(5E)-5-{[3-(4-BROMOPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE}-3-PENTYL-2-THIOXO-1,3-THIAZOLIDIN-4-ONE
CAS No.307953-08-8

Synthetic Route by SureRoute

1. ACTAFN590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTAFN590 route product structure diagram
    ACTAFN590307953-08-8
Inquiry

2. ACTAFN590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTAFN590 route product structure diagram
    ACTAFN590307953-08-8
Inquiry

Comments (0)